263 related articles for article (PubMed ID: 19825182)
1. Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A.
Hoque M; Hanauske-Abel HM; Palumbo P; Saxena D; D'Alliessi Gandolfi D; Park MH; Pe'ery T; Mathews MB
Retrovirology; 2009 Oct; 6():90. PubMed ID: 19825182
[TBL] [Abstract][Full Text] [Related]
2. Blocking eIF5A modification in cervical cancer cells alters the expression of cancer-related genes and suppresses cell proliferation.
Mémin E; Hoque M; Jain MR; Heller DS; Li H; Cracchiolo B; Hanauske-Abel HM; Pe'ery T; Mathews MB
Cancer Res; 2014 Jan; 74(2):552-62. PubMed ID: 24220243
[TBL] [Abstract][Full Text] [Related]
3. Antiretroviral effects of deoxyhypusyl hydroxylase inhibitors: a hypusine-dependent host cell mechanism for replication of human immunodeficiency virus type 1 (HIV-1).
Andrus L; Szabo P; Grady RW; Hanauske AR; Huima-Byron T; Slowinska B; Zagulska S; Hanauske-Abel HM
Biochem Pharmacol; 1998 Jun; 55(11):1807-18. PubMed ID: 9714299
[TBL] [Abstract][Full Text] [Related]
4. Targeting deoxyhypusine hydroxylase activity impairs cap-independent translation initiation driven by the 5'untranslated region of the HIV-1, HTLV-1, and MMTV mRNAs.
Cáceres CJ; Angulo J; Contreras N; Pino K; Vera-Otarola J; López-Lastra M
Antiviral Res; 2016 Oct; 134():192-206. PubMed ID: 27633452
[TBL] [Abstract][Full Text] [Related]
5. A unique modification of the eukaryotic initiation factor 5A shows the presence of the complete hypusine pathway in Leishmania donovani.
Chawla B; Kumar RR; Tyagi N; Subramanian G; Srinivasan N; Park MH; Madhubala R
PLoS One; 2012; 7(3):e33138. PubMed ID: 22438895
[TBL] [Abstract][Full Text] [Related]
6. Specificity of the deoxyhypusine hydroxylase-eukaryotic translation initiation factor (eIF5A) interaction: identification of amino acid residues of the enzyme required for binding of its substrate, deoxyhypusine-containing eIF5A.
Kang KR; Kim YS; Wolff EC; Park MH
J Biol Chem; 2007 Mar; 282(11):8300-8. PubMed ID: 17213197
[TBL] [Abstract][Full Text] [Related]
7. The post-translational synthesis of a polyamine-derived amino acid, hypusine, in the eukaryotic translation initiation factor 5A (eIF5A).
Park MH
J Biochem; 2006 Feb; 139(2):161-9. PubMed ID: 16452303
[TBL] [Abstract][Full Text] [Related]
8. Production of active recombinant eIF5A: reconstitution in E.coli of eukaryotic hypusine modification of eIF5A by its coexpression with modifying enzymes.
Park JH; Dias CA; Lee SB; Valentini SR; Sokabe M; Fraser CS; Park MH
Protein Eng Des Sel; 2011 Mar; 24(3):301-9. PubMed ID: 21131325
[TBL] [Abstract][Full Text] [Related]
9. A hypusine-eIF5A-PEAK1 switch regulates the pathogenesis of pancreatic cancer.
Fujimura K; Wright T; Strnadel J; Kaushal S; Metildi C; Lowy AM; Bouvet M; Kelber JA; Klemke RL
Cancer Res; 2014 Nov; 74(22):6671-81. PubMed ID: 25261239
[TBL] [Abstract][Full Text] [Related]
10. Post-translational formation of hypusine in eIF5A: implications in human neurodevelopment.
Park MH; Kar RK; Banka S; Ziegler A; Chung WK
Amino Acids; 2022 Apr; 54(4):485-499. PubMed ID: 34273022
[TBL] [Abstract][Full Text] [Related]
11. Deoxyhypusine Modification of Eukaryotic Translation Initiation Factor 5A (eIF5A) Is Essential for Trypanosoma brucei Growth and for Expression of Polyprolyl-containing Proteins.
Nguyen S; Leija C; Kinch L; Regmi S; Li Q; Grishin NV; Phillips MA
J Biol Chem; 2015 Aug; 290(32):19987-98. PubMed ID: 26082486
[TBL] [Abstract][Full Text] [Related]
12. Synergistic drug combination GC7/DFMO suppresses hypusine/spermidine-dependent eIF5A activation and induces apoptotic cell death in neuroblastoma.
Schultz CR; Geerts D; Mooney M; El-Khawaja R; Koster J; Bachmann AS
Biochem J; 2018 Jan; 475(2):531-545. PubMed ID: 29295892
[TBL] [Abstract][Full Text] [Related]
13. Drug-Based Lead Discovery: The Novel Ablative Antiretroviral Profile of Deferiprone in HIV-1-Infected Cells and in HIV-Infected Treatment-Naive Subjects of a Double-Blind, Placebo-Controlled, Randomized Exploratory Trial.
Saxena D; Spino M; Tricta F; Connelly J; Cracchiolo BM; Hanauske AR; D'Alliessi Gandolfi D; Mathews MB; Karn J; Holland B; Park MH; Pe'ery T; Palumbo PE; Hanauske-Abel HM
PLoS One; 2016; 11(5):e0154842. PubMed ID: 27191165
[TBL] [Abstract][Full Text] [Related]
14. Posttranslational synthesis of hypusine: evolutionary progression and specificity of the hypusine modification.
Wolff EC; Kang KR; Kim YS; Park MH
Amino Acids; 2007 Aug; 33(2):341-50. PubMed ID: 17476569
[TBL] [Abstract][Full Text] [Related]
15. Bi-allelic variants in DOHH, catalyzing the last step of hypusine biosynthesis, are associated with a neurodevelopmental disorder.
Ziegler A; Steindl K; Hanner AS; Kar RK; Prouteau C; Boland A; Deleuze JF; Coubes C; Bézieau S; Küry S; Maystadt I; Le Mao M; Lenaers G; Navet B; Faivre L; Tran Mau-Them F; Zanoni P; Chung WK; Rauch A; Bonneau D; Park MH
Am J Hum Genet; 2022 Aug; 109(8):1549-1558. PubMed ID: 35858628
[TBL] [Abstract][Full Text] [Related]
16. Assay of deoxyhypusine hydroxylase activity.
Park JH; Wolff EC; Park MH
Methods Mol Biol; 2011; 720():207-16. PubMed ID: 21318876
[TBL] [Abstract][Full Text] [Related]
17. Molecular cloning, expression, and structural prediction of deoxyhypusine hydroxylase: a HEAT-repeat-containing metalloenzyme.
Park JH; Aravind L; Wolff EC; Kaevel J; Kim YS; Park MH
Proc Natl Acad Sci U S A; 2006 Jan; 103(1):51-6. PubMed ID: 16371467
[TBL] [Abstract][Full Text] [Related]
18. Functional significance of eIF5A and its hypusine modification in eukaryotes.
Park MH; Nishimura K; Zanelli CF; Valentini SR
Amino Acids; 2010 Feb; 38(2):491-500. PubMed ID: 19997760
[TBL] [Abstract][Full Text] [Related]
19. Neuron-specific ablation of eIF5A or deoxyhypusine synthase leads to impairments in growth, viability, neurodevelopment, and cognitive functions in mice.
Kar RK; Hanner AS; Starost MF; Springer D; Mastracci TL; Mirmira RG; Park MH
J Biol Chem; 2021 Nov; 297(5):101333. PubMed ID: 34688659
[TBL] [Abstract][Full Text] [Related]
20. A novel mouse model for inhibition of DOHH-mediated hypusine modification reveals a crucial function in embryonic development, proliferation and oncogenic transformation.
Sievert H; Pällmann N; Miller KK; Hermans-Borgmeyer I; Venz S; Sendoel A; Preukschas M; Schweizer M; Boettcher S; Janiesch PC; Streichert T; Walther R; Hengartner MO; Manz MG; Brümmendorf TH; Bokemeyer C; Braig M; Hauber J; Duncan KE; Balabanov S
Dis Model Mech; 2014 Aug; 7(8):963-76. PubMed ID: 24832488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
